| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.677 | 31.543 | 38.998 | 40.401 | 28.316 | 47.145 | 91.139 | 37.088 |
| Total Income - EUR | - | - | 2.677 | 31.543 | 38.998 | 40.401 | 28.480 | 47.167 | 91.169 | 37.088 |
| Total Expenses - EUR | - | - | 253 | 452 | 559 | 623 | 687 | 705 | 745 | 1.613 |
| Gross Profit/Loss - EUR | - | - | 2.424 | 31.091 | 38.439 | 39.779 | 27.793 | 46.462 | 90.423 | 35.476 |
| Net Profit/Loss - EUR | - | - | 2.344 | 30.145 | 37.234 | 38.619 | 26.938 | 45.047 | 75.956 | 29.799 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cormed Hematologie Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 2.577 | 33.137 | 38.162 | 39.323 | 27.199 | 45.611 | 84.437 | 31.659 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 3.319 | 3.672 | 5.500 | 2.123 | 502 | 20.811 | 21.727 |
| Cash | - | - | 2.577 | 29.818 | 34.491 | 33.823 | 25.076 | 45.109 | 63.626 | 9.932 |
| Shareholders Funds | - | - | 2.388 | 32.488 | 37.276 | 38.661 | 26.978 | 45.088 | 75.996 | 29.840 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 194 | 649 | 887 | 662 | 221 | 524 | 8.441 | 1.820 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cormed Hematologie Consulting Srl